BRUKINSA 160 mg/1
zanubrutinib · TABLET, FILM COATED · BeOne Medicines USA, Inc.
No Recall History
Plain English
BRUKINSA is a tablet, film coated containing zanubrutinib at 160 mg/1, taken oral. Manufactured by BeOne Medicines USA, Inc..
Key Facts
- Brand Name
- BRUKINSA
- Generic Name
- zanubrutinib
- NDC Code (Product)
72579-122- Manufacturer
- BeOne Medicines USA, Inc.
- Strength
- 160 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA218785
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 08/18/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is BRUKINSA used for?
BRUKINSA contains zanubrutinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is BRUKINSA a controlled substance?
BRUKINSA is not classified as a controlled substance by the DEA.
What is the generic name for BRUKINSA?
The generic name for BRUKINSA is zanubrutinib. There are no other listed brand versions of zanubrutinib.
What is the NDC code for BRUKINSA 160 mg/1?
The NDC (National Drug Code) for BRUKINSA 160 mg/1 is 72579-122, listed by BeOne Medicines USA, Inc..
Other BRUKINSA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)